Mast cells are important for eradication of intestinal nematodes; however, their precise mechanisms of action have remained elusive, especially in the early phase of infection. We found that Spi-B-deficient mice had increased numbers of mast cells and rapidly expelled the Heligmosomoides polygyrus (Hp) nematode. This was accompanied by induction of interleukin-13 (IL-13)-producing group 2 innate lymphoid cells (ILC2) and goblet cell hyperplasia. Immediately after Hp infection, mast cells were rapidly activated to produce IL-33 in response to ATP released from apoptotic intestinal epithelial cells. In vivo inhibition of the P2X7 ATP receptor rendered the Spi-B-deficient mice susceptible to Hp, concomitant with elimination of mast cell activation and IL-13-producing ILC2 induction. These results uncover a previously unknown role for mast cells in innate immunity in that activation of mast cells by ATP orchestrates the development of a protective type 2 immune response, in part by producing IL-33, which contributes to ILC2 activation.
INTRODUCTION
More than 60% of the world population is at risk of helminth infections, which are widely distributed in tropical and subtropical regions. Infections with intestinal helminths are major causes of malnutrition and increased susceptibility to lethal pathogens (Salgame et al., 2013) and are major socioeconomic problems in developing countries. Immunologically, intestinal helminths are unique in typically inducing type 2 immune responses.
Type 2 immune responses contribute to both host tolerance and protection (Anthony et al., 2007; Chen et al., 2012; Gause et al., 2013) but are also associated with pathological conditions such as allergic rhinitis and asthma. These responses are characterized by production of cytokines, such as interleukin-4 (IL-4), IL-5, and IL-13, secreted by classical type 2 helper T (Th2) cells, as well as by innate immune cells, such as group 2 innate lymphoid cells (ILC2s), basophils, eosinophils, and mast cells (Licona-Limó n et al., 2013) .
Heligmosomoides polygyrus (Hp) is an intestinal helminth, similar to human intestinal nematodes, that causes an asymptomatic chronic infection in mice. Several studies have reported that type 2 immune responses are crucial for protective immunity against Hp. Involvement of IL-4 in Hp resistance suggests the importance of Th2 cells (Finkelman et al., 1997; Horsnell et al., 2013) . In addition to acquired immunity, contributions of innate immunity have been demonstrated in the resistance to Hp. Given that enhanced expulsion of Hp correlates with mast cell numbers (Reynolds et al., 2012) and that mast cell deficiency results in impaired resistance (Hepworth et al., 2012) , these innate cells are thought to be important for protection against Hp. Nevertheless, it remains unclear how mast cells are involved in clearance of Hp infection.
Spi-B belongs to the Ets (E26 transformation-specific) transcription factor family. More than 30 genes found in several animal species, including humans and mice, are members of this family. Spi-B is expressed in the hematopoietic cells required for generation of lymphoid progenitor cells and is a key regulator for B cells (Singh et al., 2005; Iwasaki et al., 2005) . It is also reported to play important roles in the development and function of plasmacytoid dendritic cells (pDCs) . We and others have recently reported that Spi-B is also essential for differentiation of intestinal epithelial microfold cells (M cells) (de Lau et al., 2012; Kanaya et al., 2012; Sato et al., 2013) , which play a crucial role in intestinal immune responses against microbial antigens in the intestinal lumen (Kanaya and Ohno, 2014 ).
These observations support the importance of Spi-B in immune responses, especially in the intestine, although the possible involvement of this transcription factor in intestinal helminth infections remains unknown.
To analyze the role of Spi-B in intestinal helminth infection, we orally infected Spi-B-deficient (Spib À/À ) mice with Hp and found that the Spib À/À mice were better protected than wild-type (WT) mice. We observed an increase in mast cell numbers that was due to the biased differentiation of common myeloid progenitors to granulocyte progenitors in the bone marrow in Spib À/À mice.
The mast cells secreted IL-33 upon activation by ATP released from intestinal epithelium damaged during Hp infection. IL-33 in turn activated ILC2 to produce IL-13, resulting in an increase of goblet cells to expel the worms. The present study thus uncovers an innate role of mast cells in activation of innate type 2 immune responses in the early phase of helminth infection.
RESULTS

Spib -/-Mice Are Resistant to Infection with the Intestinal Helminth Hp
We orally infected Spib À/À mice with 200 Hp L3 larvae and then evaluated the course of infection by counting worm eggs in feces ( Figure 1A ). In WT mice, egg production was obvious at 12 days and peaked at 3 weeks, maintaining a plateau for more than 1 month after infection. In sharp contrast, there were far fewer Hp eggs in Spib À/À mice compared to WT mice. Consistent with the decrease in egg numbers, fewer adult worms were recovered from the small intestine of Spib À/À mice than from WT mice ( Figure 1B) . Macroscopically, the small intestines of Spib À/À mice were edematous, elongated, and heavier Hp infection were counterstained with Alcian blue. The Alcian blue-stained area was quantified using ImageJ, and the number of goblet cells per villus (n = 15) of the duodenum was counted. Data are mean ± SD of five mice. Similar results were obtained from three replicate experiments. Scale bars, 100 mm. Please see also Figure S1 .
( Figure S1 ). Histopathological analyses revealed that Alcian blue-stained goblet cells were increased in the duodenum only in Spib À/À mice at day 7 after infection ( Figure 1C Figure 2A ). Flow cytometric analysis confirmed the production of IL-13 protein and showed more IL-13-producing cells in the Spib À/À than in WT mice at day 7 after infection ( Figure 2B ). IL-13 + cells were not detected before infection (data not shown). Importantly, the majority of IL-13-expressing cells were Lin À and CD4 À , indicating that classical Th2 cells were unlikely the source of IL-13 ( Figure 2B ).
Given the enhanced Gata3 expression and the absence of Il4, we hypothesized that the source of IL-13 could be ILC2, which express GATA3 and secrete IL-13, but not IL-4 (Moro et al., 2010) . Indeed, infection with Hp increased ILC2, identified as Lin À c-Kit + Sca1 + and KLRG-1 + , among LP cells from the small intestine both in WT and Spib À/À mice, with significantly more ILC2 in the Spib À/À mice ( Figure 2C ). Of note, the IL-13 + population among ILC2 was easily detected in Spib À/À mice, but only marginal in WT mice, 7 days after Hp infection ( Figure 2C ). These results demonstrate that the Hp resistance in Spib À/À mice is likely attributable to the increase of IL-13-producing ILC2. eosinophils, in Spib À/À mice ( Figure 3A ). Granulocytic cells were also increased in the peritoneal cavity and spleen (Figures S3A and S3B) . By contrast, there was no difference in the number of lymphoid or dendritic cells (DCs), despite a trend for increased T cell and natural killer (NK) cell numbers in Spib À/À mice. pDCs were slightly, but significantly, reduced as reported ( Figure S3C ) . All myeloid lineage cells are generated from a common myeloid progenitor (CMP) after stepwise development from hematopoietic stem cells (HSCs) (Luis et al., 2012) . The CMP further bi-directionally differentiates into the megakaryocyte erythrocyte progenitor (MEP) and the granulocyte monocyte progenitor (GMP), which gives rise to all granulocyte lineage cells ( Figure S3D ). To understand the mechanism underlying the increase in granulocytes in Spib À/À mice, we analyzed these developmental processes. The number of total mononuclear cells, Lin and FcgRII/III (Coppin et al., 2016) . While these three progenitors were numerically similar in WT bone marrow, there were more GMP and fewer MEP in the Spib À/À mice ( Figures 3C and 3D ).
These results suggest that the lack of Spi-B preferentially skews CMP to differentiate into GMP, resulting in the increase in granulocytes. The notion is supported by the reduction of erythrocytes and platelets, both of which are derived from MEP, in the Spib À/À mice ( Figures S3E and S3F ).
Lack of Spi-B Augments CMP Differentiation into GMP due to Altering the Balance between PU.1 and GATA-1 Transcription Factors The observed increase in GMP due to Spi-B deficiency raises the possibility that Spi-B acts on CMP to regulate their bi-directional differentiation into GMP and MEP. We therefore asked whether Spi-B is expressed in CMP. Real-time RT-PCR analysis detected Spib mRNA in the bone marrow CMP of WT mice and confirmed its absence in the Spib À/À ( Figure 4A ). Differentiation of CMP is precisely regulated by the balance of two lineage-specific transcription factors, GATA-1 and PU.1 (Nerlov et al., 2000; Rekhtman et al., 1999; Zhang et al., 1999) . Expression of PU.1 leads to differentiation toward GMP (Nutt et al., 2005) , whereas GATA-1 enhances MEP differentiation (Kuhl et al., 2005) . Accordingly, we analyzed whether the altered expression of these transcription factors is involved in the skewed CMP differentiation into GMP in Spib À/À mice. Of interest, CMP from Spib À/À mice expressed more Spi1 (encoding PU.1) and less
Gata1 mRNA compared to WT mice ( Figure 4A ). By contrast, expression of Cebpa mRNA, encoding C/EBPa, which is known to enhance GMP differentiation (Yeamans et al., 2007) , was comparable in Spib À/À and WT mice ( Figure 4A ). These results led us to hypothesize that Spi-B is involved in CMP differentiation by regulating the balance between PU.1 and GATA-1.
To test this possibility, we evaluated the impact of forced expression of Spi-B on the expression of these transcription factors. Sorted CMP were transduced with a recombinant lentivirus expressing Spi-B, and Spi1 and Gata1 mRNAs were quantified ( Figure 4B ). Transduction with the Spi-B lentivirus successfully induced the expression of Spib mRNA in Spib À/À CMP, otherwise no Spib expression was detected ( Figure 4B ). As expected, expression of Spi-B altered the high Spi1 and low Gata1 expression in Spib À/À CMP to restore their expression equivalent to those in WT CMP ( Figure 4B ). Similar effects of exogenous Spi-B on Spi1 and Gata1 expression were observed even in Spi-B-sufficient CMP obtained from WT mice. Expression of PU.1 protein was also examined. In accordance with the mRNA expression data, a larger proportion of Spib À/À CMP (42.1%) than WT (9.24%) expressed PU.1 after transduction with mock virus ( Figure 4C ). (Hepworth et al., 2012) . Consistent with this notion, mast cells were rapidly increased in the small intestinal LP of Spib À/À mice compared to WT mice in response to Hp infection ( Figure 5A ), in contrast to basophils and eosinophils, which were similar in both mouse strains ( Figure S4A ). Indeed, many mast cells identified by staining with toluidine blue accumulated in the LP of the duodenum in Spib À/À mice ( Figure 5B ). To evaluate a causal relationship between the increased number of mast cells and the resistance to Hp in Spib À/À mice, we depleted mast cells by treatment with the anti-c-Kit antibody ACK (Vanderford et al., 2010) . This manipulation reduced the mast cells in Spib À/À mice to the equivalent of that in WT mice ( Figure 5C ) and completely eliminated their Hp resistance ( Figure 5D ). In WT mice, mast cells gradually increased and reached their peak 14 days after infection ( Figure 5A ), when many adult worms had established firm parasitism, whereas Spib À/À mice harbored much fewer worms ( Figure 1B) . Anti-mouse c-Kit monoclonal antibody (ACK) treatment also reduced the number of mast cells in WT mice (Figure 5C ) and slightly, but significantly, impaired Hp expulsion at later phases of infection. By contrast, depletion of basophils using Ba103 antibodies did not affect Hp resistance in Spib À/À mice ( Figure S4B ). These results indicate that increased mast cells are critical for protecting Spib À/À mice from Hp infection at the early phase by inhibiting settlement of adult worms and that mast cells also contribute to protection in WT mice at a later phase.
Mast Cells Produce IL-33 upon Activation by EpitheliumDerived ATP through the P2X7 Adenosine Receptor We next explored how mast cells contribute to Hp resistance in Spib À/À mice. It has been reported that bone-marrow-derived mast cells secrete ILC2-activating IL-33 upon stimulation in vitro (Tung et al., 2014) . Since IL-13-producing ILC2 were increased in these mice ( Figure 2 ) and depletion of mast cells severely reduced ILC2 ( Figure 5E ), we postulated that mast cells could directly activate ILC2 by producing the IL-33 crucial for their activation. LP mast cells from the small intestines were collected from Spib À/À and WT mice infected with Hp and then analyzed for mRNA encoding this cytokine. Significantly more IL-33 transcripts were detected in Spib À/À mice compared to WT mice as early as day 1 post-infection ( Figure 6A ). Furthermore, flow cytometric analyses revealed that Spib À/À mice contained more mast cells expressing IL-33 protein at days 7 after infection ( Figure 6B ). As reported (Hepworth et al., 2012) , mast cell-deficient Kit W-sh/W-sh (Wsh) mice are more susceptible to Hp as judged by increased egg production compared with WT mice ( Figure 6C ). Transfer of Wsh mice with WT mast cells significantly reduced the egg production to the level comparable to WT mice, in association with increased expression of mRNA encoding IL-33 and IL-13, and with increased ILC2 (Figures 6D and  6E ). However, Wsh mice reconstituted with IL-33-deficient mast cells had a similar number of eggs in their feces as the unmanipulated Wsh mice and failed to mount type 2 responses. These results clearly demonstrate that IL-33 derived from mast cells contributes to protection against Hp. We next addressed how mast cells are activated to produce IL-33 in response to Hp infection. It has been reported that IgE Data are mean ± SD from three mice. Asterisks denote statistical significance at *p < 0.05 using Student's t test or two-way ANOVA. Similar results were obtained from three replicate experiments. were then monitored by counting egg production in feces at 9 (left) and 14 (right) days after infection as in Figure 3A . Data are mean ± SD from three mice. Error
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bound to FcεRI on mast cells provides activation signals after crosslinking with the cognate antigen (Sakurai et al., 2004) . However, IgE-mediated activation of mast cells seems an unlikely mechanism here because the serum IgE concentrations were rather low and comparable to WT mice in Spib À/À mice at the early phase (day 5) of the infection ( Figure S5 ), when IL-13 was already highly induced ( Figure 2 ). An alternative activation pathway was evaluated by focusing on extracellular ATP, since intestinal mast cells have been reported to exert their pathological roles in inflammation through P2X purinoceptors (Kurashima et al., 2012) . To test this idea in vitro, we cultured LP mast cells with ATP and analyzed them for their activation status. Addition of ATP led to degranulation, as detected by exposure of the degranulation marker CD63, and, more importantly, to the release of IL-33 from mast cells ( Figure 6F ). These responses were completely inhibited in the presence of suramin, a P2X receptor inhibitor, indicating that mast cells were activated to secrete IL-33 in response to extracellular ATP through a P2X receptor. As L3 larvae of Hp penetrate the epithelium of the small intestine, ATP may be released from damaged epithelial cells. To assess this possibility, we cultured intestinal tissues isolated from WT and Spib À/À mice with and without Hp infection and measured ATP concentrations in the supernatants. No ATP was released from intestines of uninfected mice, reflecting the intact intestinal tissue. By contrast, extracellular ATP was detected as early as 6 hr after infection and reached its maximum 20 hr after infection ( Figure 6G ). In the same intestinal tissue culture supernatant, IL-33 was marginally detectable during the first 24 hr of infection and increased thereafter ( Figure 6G ). Of note, the amount of IL-33 was comparable between WT and Spib À/À mice, suggesting that this could not account for the enhanced ILC2 induction in Spib À/À mice. Consistent with the notion that ATP is released by apoptotic cells (Elliott et al., 2009) , the intestinal epithelium underwent apoptosis as determined by TUNEL staining ( Figure 6H ). These observations, including the comparable responsiveness of mast cells to ATP, as well as ATP release from the Hp-infected intestinal tissues in WT and Spib À/À mice, suggest that the increase in mast cell numbers, resulting in augmented IL-33 secretion, is responsible for the early eradication of Hp in Spib À/À mice.
We next asked whether ATP-mediated activation of mast cells plays a crucial role in vivo in the early HP eradication in Spib À/À mice. Real-time qPCR revealed that among the P2rx genes encoding P2X purinoceptors examined, P2rx7 was predominantly expressed in LP mast cells ( Figure S6A ), as reported previously (Kurashima et al., 2012) . Therefore, the involvement of this receptor in mast cell activation was evaluated in vivo by treating mice with brilliant blue G (BBG), a specific P2X7 inhibitor (Donnelly-Roberts and Jarvis, 2007) . BBG administration rendered Spib À/À mice less resistant and WT mice slightly more susceptible to Hp infection compared to untreated controls ( Figure 7A ). Although, unlike ACK c-Kit antibody treatment, BBG treatment did not alter the number of mast cells, their production of IL-33 was suppressed both in WT and Spib À/À mice ( Figures 7B and   7C ). Furthermore, the increase of ILC2 and their production of IL-13 were also suppressed, not only in Spib
, but also in WT mice (Figures 7D and 7E) . We also confirmed that the intestinal epithelium and ILC2 do not express P2rx7 mRNA ( Figure S6B ). Taken together, these observations indicate that the inhibition of P2X7 purinoceptor-mediated mast cell activation eliminates the protection against Hp, both in Spib À/À and WT mice, most likely due to the lack of mast cell-derived IL-33.
DISCUSSION
Here, we have reported an innate protective mechanism against an intestinal helminth and define the pathway: ATP released by parasite-damaged intestinal epithelial cells activates mast cells to secrete IL-33 for induction of IL-13-producing ILC2. It has been reported that innate responses, especially induction of IL-13-producing ILC2, are crucial for protection against nematodes (Herbert et al., 2009; Hashimoto et al., 2009; Hasnain et al., 2011; Koyasu and Moro, 2011; Licona-Limó n et al., 2013; Oliphant et al., 2014) . IL-33 is a potent ILC2-inducible cytokine, reportedly released from damaging cells, that acts as a damage-associated molecular pattern (DAMP) (Le et al., 2013) . We here have shown that mast cells are rapidly expanded and secrete IL-33 in response to Hp infection in both WT and Spib À/À mice.
Mast cell-deficient mice have been shown to be slow in expelling Hp in association with impaired type 2 immune responses, including low expression of IL-33 (Hepworth et al., 2012) . Based on their observation that in vitro stimulation of mast cells with Hp antigens did not lead to IL-33 production, these authors suggested that mast cells regulate the production of cytokines, including IL-33, by intestinal epithelial cells rather than secreting these cytokines themselves (Hepworth et al., 2012) . In our study, we found that, rather than Hp antigens, extracellular ATP acting through the P2X7 purinoceptor on mast cells induced rapid IL-33 production by mast cells both in Spib À/À and WT mice. Extracellular ATP also acts as a DAMP, being readily released during the early stages of apoptosis (Elliott et al., 2009) . Indeed, we confirmed that the intestinal tissues bars, *p < 0.05, **p < 0.01, ***p < 0.001, calculated by one-way ANOVA followed by Tukey's multiple comparisons test. Similar results were obtained from three replicate experiments. (D and E) Measurement of Il33 and Il13 transcript expressions and ILC2 numbers in the adoptive transfer experiment shown in (C). mRNA encoding IL-33 and IL-13 in the small intestinal tissues (D) and ILC2 in LP (E) isolated from the indicated mice or recipients 7 days after infection with Hp were quantified. Data are mean ± SD from three mice. Error bars, *p < 0.05 calculated by one-way ANOVA followed by Tukey's multiple comparisons test. (F) Sorted mast cells from uninfected WT and Spib À/À mice were cultured with ATP in the absence or presence of suramin. Cultured mast cells and culture supernatants were analyzed for surface expression of the CD63 degranulation marker by flow cytometry (left) and for production of IL-33 using ELISA (right), respectively. Asterisks denote statistical significance at *p < 0.05 using two-way ANOVA.
(G) Small intestinal tissues isolated from WT and Spib À/À mice at the indicated hours after Hp infection were cultured for 1 hr and the ATP concentration in the culture supernatants was measured.
(H) The same tissues were immediately stained with DAPI (blue) and assayed by TUNEL (red). Scale bars, 100 mm. Data are mean ± SD from three mice. Similar results were obtained from three replicate experiments.
undergo apoptosis upon Hp infection. We also showed that mast cell depletion, as well as suppression of mast cell-derived IL-33 by P2X7 inhibition in vivo, rendered not only Spib À/À , but also WT mice less resistant to Hp infection. Furthermore, adoptive transfer of mast cells into mast cell-deficient Wsh mice clearly demonstrated that mast cell-derived IL-33 was critical for protection at early phases of Hp infection. Thus, our study has shed lights on the role of mast cells in intestinal helminth infection; IL-33 secreted by mast cells in response to extracellular ATP from Hp-injured intestinal epithelium is important for ILC2 induction, which is crucial for worm eradication in the early phase of helminth infection. In Spi-B-KO (knockout) mice, increased mast cells are crucial for preventing the settlement of adult worms. In contrast, WT mice do not have enough mast cells to do so in the early phase of infection, and the mast cells are gradually increased in response to existing adult worms. However, the mast cells are unable to solely eradicate already parasitizing adult worms because they firmly adhere to the epithelial layer by twisting around villi with their coil-form body. Thus, adult Hp could parasitize even in the presence of abundant mast cells. This might be a major reason why Hp par- inhibitor brilliant blue G (BBG) were infected with Hp, and infection was monitored by counting egg production in feces (A) as in Figure 3A . The number of LP mast cells (B), the expression of IL-33 in gated mast cells (C), the number of ILC2 (D), and ILC2 IL-13 production (E) were analyzed 7 days after infection. Data are mean ± SD from three mice. Error bars, *p < 0.05, **p < 0.01, as calculated by Mann-Whitney test or one-way ANOVA. Similar results were obtained from three replicate experiments.
asitizes for a long time, in contrast to Nippostrogylus brasiliensis and Strogyloides venezuelensis, both of which are eradicated within 2 weeks. It would be interesting to see whether IL-33 release from mast cells can play a physiological role in the infection of these parasites in WT mice. Mast cells are known to release numerous molecules other than IL-33. We detected IL-25, LTD4, PGD2, and mMCP1, a protease with chymase activity, in the culture supernatant of purified mast cells stimulated with ATP. The expression of these molecules was comparable between WT and Spib À/À mast cells (data not shown). Among them, IL-25, but not IL-33, was reported to play a role in Hp expulsion in WT mice (Zaiss et al., 2013) . Proteases from mast cells are reported to cleave IL-33 to a more bioactive form (Lefranç ais et al., 2014) . Thus, in addition to IL-33, these other molecules could also be involved in mast cell-mediated protection against Hp.
That Il33 À/À mice were more susceptible to Hp compared with Wsh mice suggests that IL-33 from cells other than mast cells also contributes to protection from Hp. A probable source of IL-33 could be the intestinal epithelium. Nematode infections cause damage to mucosal epithelial cells, resulting in the release of DAMPs, including IL-33 (Zaph et al., 2007) . However, IL-33 was barely detectable in our intestinal tissue cultures during the first 24 hr after Hp infection, although there was a subsequent increase at day 3. Nevertheless, this is unlikely the main source of IL-33 for the rapid ILC2 induction observed in Spib
, but not WT, mice, since the amount of IL-33 was comparable between WT and Spib À/À mice.
We also found that the expansion of mast cells and granulocytes associated with reduced numbers of erythrocytes and platelets in Spib À/À mice was due to biased differentiation of CMP to GMP over MEP. Cross-antagonism between the PU.1 and GATA-1 transcription factors plays a decisive role in the differentiation of CMP into GMP and MEP (Chou et al., 2009) . PU.1 is crucial for GMP, whereas GATA-1 is for MEP, and the overriding differentiation pathway is determined by which factor has the highest activity in the CMP. The dominant expression of PU.1 over GATA-1 in Spi-B-deficient CMP and the normalization of their balance by the reinduction of Spi-B strongly suggest that Spi-B regulates this functional cross-antagonism between PU.1 and GATA-1 in CMP. In the Spib
, the lack of Spi-B in CMP results in higher PU.1 expression, leading to the observed increase in granulocytes. These findings thus reveal a hematopoietic regulatory role for Spi-B in myeloid lineage differentiation.
As (Kanaya and Ohno, 2014) . However, our experiments using bone marrow chimeric mice revealed that Spi-B deficiency in bone marrow cells determined the resistance phenotype, excluding the involvement in Hp resistance of the lack of M cells and also the increase in medullary thymic epithelial cells observed in Spib À/À mice (Akiyama et al., 2014) . A possible contribution of pDC, another Spi-B-expressing cell type, to Hp resistance is unlikely, since pDCs are only slightly decreased in Spib À/À mice, and there have been no studies reporting the involvement of pDCs in helminth eradication; nonetheless, a possible contribution by pDCs could not be formally excluded.
Resistance to Hp infection observed in Spib À/À mice seems to be due primarily to the quantity rather than the quality of mast cells, because ATP release from intestinal tissues after Hp infection and secretion of IL-33 from mast cells in response to ATP in vitro was comparable in WT and Spib À/À mice. Migration of mast cells to the small intestine is reported to be regulated by CXCR2 expressed on mast cells and its ligand in the intestine. No significant difference in the expression of mRNA encoding CXCR2 and its major ligand MIP-2 was observed in the small intestines in Spib À/À mice (data not shown), suggesting that the increase in the number of mast cells in the small intestines in Spib À/À mice compared to WT mice is not likely due to the enhanced recruitment rate, but rather due mainly to recruitment from a preexisting expanded mast cell pool, without changing the recruitment efficiency and/or inducing proliferation of mast cells in situ. Indeed, Il2rb transgenic mice have an expanded population of mast cells and also an Hp-resistant phenotype, including an initial reduction of egg production and goblet cell hyperplasia, similar to Spib À/À mice (Suwa et al., 1995) , supporting the notion that the increase in mast cells is important for early Hp eradication. Given that mast cells themselves are activated by IL-33 (Sibilano et al., 2014) Figure 6C ), and the inhibition of the P2X7 ATP receptor reduces IL-33 secretion and subsequent ILC2 induction in WT mice as well. In summary, we here show a function of mast cells in initiation of ILC2 innate immune responses against nematode infection. Mast cells rapidly secrete IL-33 in response to extracellular ATP released from injured intestinal epithelial cells during nematode invasion in the intestinal tissue, which in turn induces IL-13-producing ILC2, ultimately resulting in goblet cell hyperplasia and mucin secretion for worm expulsion. Our findings provide insights into mucosal protection exerted by mast cells against an intestinal nematode, especially in the early phase of infection. Vaccine development against nematodes is an important global issue. It would be of substantial benefit to reduce the initial worm burden by activating innate immunity, given that humans are repeatedly infected by nematodes likely due to poor adaptive memory responses. Increasing or activating mast cells can be an attractive and effective strategy for controlling helminth infections.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice Spib À/À mice, 10 week-old on the C57BL/6J background Kanaya et al., 2012) , and age matched male C57BL/6J mice purchased from Charles River Laboratories Japan (Yokohama, Japan) were used for experiments. All mice were maintained under conventional conditions at the Graduate School of Medical Life Science, Yokohama City University (YCU). All experiments using animals were reviewed and approved by the Committee for Ethics on Animal Experiments of the YCU, and were conducted under the control of the Guidelines for Animal Experiments in the YCU and RIKEN and the Law (No. 105) and Notification (No. 6) of the Japanese Government.
METHOD DETAILS Heligmosomoides polygyrus Infection
Hp was maintained by serial passages in live mice. For experimental infections, feces containing eggs from infected mice were cultured on wet filter paper to allow the eggs to hatch followed by development to infectious L3 larvae. Mice were orally infected with 200 L3 larvae using gastric intubation. Infection was monitored by detecting eggs in the feces.
Histological Examinations
Tissues were fixed in 4% paraformaldehyde and embedded in paraffin. Tissue sections (5 mM) were stained with hematoxylin and eosin solution and TUNEL staining. For observing the distribution of goblet cells, small intestinal sections were stained with Alcian blue and the Eosinophil -Mast Cell Stain Kit.
Real-Time Quantitative Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
Total RNA was extracted from sorted cells using an RNeasy mini kit and was reverse-transcribed with RiverTra Ace to synthesize cDNA. The genes of interest were quantified by a Thermal Cycler Dice Real Time System. PCR was performed according to the manufacturer's protocols. The expression of each target gene was quantified from the difference in the cycle threshold (Ct) between the Gapdh gene and the target genes using the following formula: Ct = Ct target gene -Ct Gapdh gene. The specific primer pairs for each gene were: Gata3, 
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical differences between two or more experimental groups were evaluated using two-tailed unpaired Student's t test or the analysis of variance (ANOVA) followed by Boneferroni post hoc test. The data whose variances were not homogeneous were analyzed using the non-parametric Mann-Whitney U test or the Kruskal-Wallis test followed by the Scheffe test. P values < 0.05 were considered statistically significant.
